Skip to content

The Mechanism of Repetitive Transcranial Magnetic Stimulation for Restless Legs Syndrome

The mechanism of repetitive transcranial magnetic stimulation for restless legs syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017556
Enrollment
Unknown
Registered
2018-08-03
Start date
2018-08-02
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless Legs Syndrome

Interventions

Group 1:rTMS
Group 2:False Stimulation

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Compliance with the clinical diagnostic criteria of International Restless Legs Syndrome Study Group: An urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs. Sometimes the urge to move is present without the uncomfortable sensations, and sometimes the arms or other body parts are involved in addition to the legs; The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting; The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues; The urge to move or unpleasant sensations are worse in the evening or night than during the day, or only occur in the evening or night. When symptoms are severe, the worsening at night may not be noticeable but must have been previously present; Symptoms are not solely accounted for by another medical or behavioral condition, such as leg cramps or habitual foot tapping; 2. Patients haven't take anti-RLS drugs for at least 4 weeks, including dopamine drugs,antiepileptic drugs,anti-anxiety/depression drugs, sedative, hypnotic drugs and other drugs which may cause cortical excitability changes.Doctors tell patients to continue to ban such drugs during treatment.

Exclusion criteria

Exclusion criteria: (1) All kinds of secondary RLS (including vitamin deficiency, iron deficiency anemia, pregnancy, diabetes, serious metabolic diseases, severe liver and kidney function injury and uremia, etc.); (2) Peripheral neuropathy and nerve root disease, neuropathic pain syndrome, epilepsy; (3) The installation of metal implants such as pacemakers, coronary stents and aneurysm clips, and the installation of ferromagnetic materials such as artificial cochlear implants; (4) Patients suffering from serious diseases of other systems; (5) long-term habits of drinking alcohol, coffee or tea and smoking.

Design outcomes

Primary

MeasureTime frame
International RLS Study Group rating scale;

Secondary

MeasureTime frame
Pittsburgh sleep quality index;Hamilton Anxiety Scale;Hamilton Depression Scale;

Countries

China

Contacts

Public ContactYuping Wang

Xuanwu Hospital, Capital Medical University

wangyuping01@sina.cn+86 010-83198273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026